Macarius Donneyong

photo of Marcarius

Macarius Donneyong, PhD, MPH

Assistant Professor
Unit / Department / Division
Outcomes and Translational Sciences
404 Riffe Building
Email Address
Phone Number

Professional Interests

Professional Interests

Nearly three out of every five adults in the United States consume prescribed medications. Dr. Donneyong’s research focuses on the safety and effectiveness of medications and medical devices. Specifically, he applies quantitative methods from epidemiology, pharmacoepidemiology, biostatistics and data analytics to analyze large healthcare databases such as health insurance claims and other linked databases which capture prescribed medication use and outcomes on their safety and effectiveness.

Research Interests

  • Drug-drug interactions
  • The role of the social determinants of health factors on the effectiveness of prescribed medications
  • Medication outcomes among racial/ethnic minorities

Learn more about Dr. Donneyong's research interests.


The Ohio State University, College of Public Health
2018 – Present: PUBHHMP 6625; Leveraging Healthcare Data for Practice and Policy Change, Principal instructor

The Ohio State University, College of Pharmacy
2017 – Present: PHR 6303; Concepts in Patient Care, Co-instructor


  • 2013, PhD, University of Louisville
  • 2009, MPH, Missouri State University
  • 2005, BSc, University of Ghana

Journal Articles

  • Ankrah D, Hallas, J, Odei J, Asenso-Boadi F, Dsane-Selby L, Donneyong MM. A review of the Ghana National Health Insurance Scheme claims database: possibilities and limits for drug utilization research. Basic & Clinical Pharmacology & Toxicology. November 2018.
  • Donneyong MM, Kulik A, Gagne JJ. Patterns of Intravenous Corticosteroid Utilization in Patients Undergoing Coronary Artery Bypass Grafting Surgery in the US. Journal of Cardiovascular Pharmacology and Therapeutics. October 2017.
  • Franklin JM, Donneyong M, Desai R, Markson L, Girman C, McKay C, Patel MD, Mavros P, Schneeweiss S. Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts: Evaluating multiple healthcare hierarchies. Journal of Comparative Effectiveness Research. September, 2017; in press.
  • Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD. Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications. Pharmacoepidemiol Drug Saf. April 2017.
  • Donneyong MM, Bykov K, Bosco-Levy P, Dong YH, Levin R, Gagne JJ. Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study. British Medical Journal (BMJ). September 2016.
  • Luo J, Seeger JD, Donneyong MM, Gagne JJ, Avorn J, Kesselheim AS. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending. JAMA Intern Med. September 2016.
  • Huang J*, Donneyong MM*, Trivedi J, Barnard A, Chaney J, Dotson A, Raymer S, Cheng A, Liu H, Slaughter MS. Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations. Ann Thorac Surg. June 2015.
  • Donneyong MM, Hornung CA, Taylor KC, Baumgartner RN, Myers JA, Eaton CB, Gorodeski EZ, Klein L, Martin LW, Shikany JM, Song Y, Li W, Manson JE. Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative. Circ Heart Fail. January 2015.